A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder.

Abstract

Correction to: Genetics in Medicine 2022; https://doi.org/10.1016/j.gim.2022.03.014In the article “A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder” by Shankar SP et al (Genet Med 2022;24:1567-1582), there was an error in the Acknowledgments section. The National Institutes of Health (NIH) grant should read U01HG007690, not 1U41HG006834-01A1. The article has been corrected online and can be accessed at https://doi.org/10.1016/j.gim.2022.03.014. Correction to: Genetics in Medicine 2022; https://doi.org/10.1016/j.gim.2022.03.014 In the article “A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder” by Shankar SP et al (Genet Med 2022;24:1567-1582), there was an error in the Acknowledgments section. The National Institutes of Health (NIH) grant should read U01HG007690, not 1U41HG006834-01A1. The article has been corrected online and can be accessed at https://doi.org/10.1016/j.gim.2022.03.014. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorderGenetics in MedicineVol. 24Issue 7PreviewDiphthamide is a post-translationally modified histidine essential for messenger RNA translation and ribosomal protein synthesis. We present evidence for DPH5 as a novel cause of embryonic lethality and profound neurodevelopmental delays (NDDs). Full-Text PDF